What is Pharmacovigilance?
Post-market medicine safety surveillance covering adverse-event reporting, signal detection, periodic safety updates, risk-management plans, and benefit-risk reassessment across jurisdictions.
Pharmacovigilance
Post-market medicine safety surveillance covering adverse-event reporting, signal detection, periodic safety updates, risk-management plans, and benefit-risk reassessment across jurisdictions.
See current Pharmacovigilance activity, then check whether the developments map to your products, sites, suppliers, markets, and internal owners.
Book a demo
Prefer to self-diagnose first? Get a free exposure assessment
Current activity
Intensifying
4500% above the prior 8-week baseline
3-month trend
48 alerts tracked
Updated 18 August 2026, 19:10
Topic context
How to read Pharmacovigilance regulatory activity
Why it matters
Pharmacovigilance developments can change product scope, supplier expectations, market access, reporting duties, and risk ownership. Foresight tracks the signals early so teams can respond before obligations become urgent.
How Foresight monitors it
Foresight monitors official sources, extracts structured regulatory intelligence, and maps alerts to a customer's products, substances, markets, and priorities so teams see the relevant signal with source evidence for review.
Frequently asked questions
Everything you need to know about Foresight's regulatory intelligence platform
Still have questions? Get in touch with our team
Join 3,500+ professionals staying ahead
Subscribe to Foresight Weekly for expert-picked regulatory developments across chemicals, sustainability, product safety, ESG, and HSE.
Free forever. Unsubscribe anytime.
Read by professionals at
